Harrow
Chrystal A. is a seasoned professional in brand management and product development, currently serving as Sr. Brand Manager for VEVYE at Harrow since August 2023. With a career spanning over a decade, Chrystal has held influential roles such as Brand Manager at CooperVision from 2020 to 2023, Associate Product Director for Botox Cosmetic at Allergan in 2018-2019, and Sr. Brand Manager & New Product Development at Eufora International from 2013 to 2018. Additional experience includes positions as Director of New Product Development at Kenra Professional (2011-2012) and Global Product Manager at Dermalogica (2008-2011). Chrystal holds a Bachelor of Business Administration in Marketing and Management from the University of Michigan's Ross School of Business.
This person is not in any offices
Harrow
2 followers
Harrow (Nasdaq: HROW) is a leading U.S. eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic prescription therapies that are accessible and affordable. Harrow owns U.S. commercial rights to ten FDA-approved ophthalmic pharmaceutical products. Harrow also owns and operates ImprimisRx, the leading U.S. ophthalmic‑focused pharmaceutical compounding business, which also serves as a mail-order pharmacy licensed to ship prescription medications in all 50 states. Harrow has non-controlling equity positions in Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc., companies that began as subsidiaries of Harrow. Harrow also owns royalty rights in four late-stage drug candidates being developed by Surface and Melt.